| A facile approach to enhance antigen response for personalized cancer vaccination AW Li, MC Sobral, S Badrinath, Y Choi, A Graveline, AG Stafford, ... Nature materials 17 (6), 528-534, 2018 | 336 | 2018 |
| Biomaterial-based scaffold for in situ chemo-immunotherapy to treat poorly immunogenic tumors H Wang, AJ Najibi, MC Sobral, BR Seo, JY Lee, D Wu, AW Li, ... Nature communications 11 (1), 5696, 2020 | 123 | 2020 |
| Metabolic labeling and targeted modulation of dendritic cells H Wang, MC Sobral, DKY Zhang, AN Cartwright, AW Li, MO Dellacherie, ... Nature materials 19 (11), 1244-1252, 2020 | 105 | 2020 |
| A vaccine targeting resistant tumours by dual T cell plus NK cell attack S Badrinath, MO Dellacherie, A Li, S Zheng, X Zhang, M Sobral, ... Nature 606 (7916), 992-998, 2022 | 83 | 2022 |
| Strategies to enhance the distribution of nanotherapeutics in the brain C Zhang, P Mastorakos, M Sobral, S Berry, E Song, E Nance, ... Journal of Controlled Release 267, 232-239, 2017 | 27 | 2017 |
| Clickable, acid labile immunosuppressive prodrugs for in vivo targeting H Wang, MC Sobral, T Snyder, Y Brudno, VS Gorantla, DJ Mooney Biomaterials science 8 (1), 266-277, 2020 | 19 | 2020 |
| Optimizing CpG spatial distribution with DNA origami for Th1-polarized therapeutic vaccination YC Zeng, OJ Young, CM Wintersinger, FM Anastassacos, JI MacDonald, ... BioRxiv, 2022.06. 08.495340, 2022 | 10 | 2022 |
| Adoptive T cell transfer and host antigen-presenting cell recruitment with cryogel scaffolds promotes long-term protection against solid tumors K Adu-Berchie, JM Brockman, Y Liu, TW To, DKY Zhang, AJ Najibi, ... Nature Communications 14 (1), 3546, 2023 | 9 | 2023 |
| Targeting tumor extracellular matrix activates the tumor-draining lymph nodes AJ Najibi, TY Shih, DKY Zhang, J Lou, MC Sobral, H Wang, ... Cancer Immunology, Immunotherapy 71 (12), 2957-2968, 2022 | 7 | 2022 |
| Establishing a quantitative endpoint for transarterial embolization from real-time pressure measurements PC Gowda, VX Chen, MC Sobral, TL Bobrow, TG Romer, AK Palepu, ... Journal of Medical Devices 15 (2), 021005, 2021 | 4 | 2021 |
| Multifunctional magnetic nanoparticles elicit anti-tumor immunity in a mouse melanoma model N Lafuente-Gómez, I de Lázaro, M Dhanjani, D García-Soriano, ... Materials Today Bio 23, 100817, 2023 | 2 | 2023 |
| Lymph node expansion predicts magnitude of vaccine immune response AJ Najibi, RS Lane, MC Sobral, BR Freedman, JG Estupinan, ... bioRxiv, 2022.10. 25.513749, 2022 | 2 | 2022 |
| Fine tuning of CpG spatial distribution with DNA origami for improved cancer vaccination YC Zeng, OJ Young, CM Wintersinger, FM Anastassacos, JI MacDonald, ... Nature Nanotechnology, 1-11, 2024 | 1 | 2024 |
| Materials-based approaches for cancer vaccination MC Sobral, DJ Mooney The Journal of Immunology 212 (2), 179-187, 2024 | 1 | 2024 |
| Enhancing adoptive T cell therapy with synergistic host immune engagement promotes long-term protection against solid tumors K Adu-Berchie, JM Brockman, Y Liu, DKY Zhang, AJ Najibi, A Stafford, ... bioRxiv, 2022.09. 10.507437, 2022 | 1 | 2022 |
| Abstract B045: Antigen-free cancer vaccine to treat poorly immunogenic tumors MC Sobral, H Wang, AJ Najibi, A Li, CS Verbeke, DJ Mooney Cancer Immunology Research 7 (2_Supplement), B045-B045, 2019 | | 2019 |
| Abstract B119: DC-recruiting biomaterial vaccine to enhance antitumor immunity AW Li, MO Dellacherie, M Sobral, OO Ali, J Kim, DJ Mooney Cancer Immunology Research 7 (2_Supplement), B119-B119, 2019 | | 2019 |
David MooneyHarvard, MIT, MichiganVerified email at seas.harvard.edu
